Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma

Abstract excerpt

Cholangiocarcinoma is a deadly cancer worldwide, associated with a poor prognosis and limited therapeutic options. Although cholangiocarcinoma accounts for less than 15% of liver primary cancer, its silent nature restricts early diagnosis and prevents efficient treatment. Therefore, it is of clinical relevance to better understand the molecular basis of cholangiocarcinoma, including the signaling pathways that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cholangiocarcinoma and Gallbladder Cancer Studies
• Share to Pancreatic and Hepatic Oncology Research
• Share to Pediatric Hepatobiliary Diseases and Treatments